Inhibition of c-Met as a Therapeutic Strategy for Esophageal Adenocarcinoma

The hepatocyte growth factor (HGF) receptor c-Met is a tyrosine kinase receptor with established oncogenic properties. We have previously shown that c-Met is usually overexpressed in esophageal adenocarcinoma (EA), yet the implications of c-Met inhibition in EA remain unknown. Three c-Met-overexpres...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Watson, Gregory A, Zhang, Xinglu, Stang, Michael T, Levy, Ryan M, Queiroz de Oliveira, Pierre E, Gooding, William E, Christensen, James G, Hughes, Steven J
Formato: Artigo
Idioma:Inglês
Publicado em: Neoplasia Press Inc. 2006
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1716014/
https://ncbi.nlm.nih.gov/pubmed/17132227
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados